Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib price?Excipients list used in dexamethasone creams?Novartis patent term dabrafenib?Atorvastatin side effects heart palpitations?When will a generic version of xiaflex be available?
See the DrugPatentWatch profile for onivyde
Information regarding discounts on onivyde is not available in the provided documents.
Onivyde (nal-IRI) is a chemotherapy drug used to treat certain types of cancer. It is a liposomal formulation of irinotecan, a topoisomerase I inhibitor [1].
Onivyde is manufactured by Servier Pharmaceuticals [2].
Specific patent expiration dates for Onivyde are not detailed in the provided information. However, for comprehensive patent information and expiry timelines, resources like DrugPatentWatch.com can offer insights [3].
Onivyde is approved for the treatment of adult patients with: * Metastatic pancreatic adenocarcinoma, in combination with fluorouracil and leucovorin [1]. * Gastric or gastroesophageal junction adenocarcinoma, in combination with fluoropyrimidine-based chemotherapy [1].
Other Questions About Onivyde :